S
RCUS icon

SignatureFD’s Arcus Biosciences RCUS Stock Holding History

SignatureFD’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40
Closed -$596 – 3422
2024
Q4 		$596 Hold
40
– – ﹤0.01% 3120
2024
Q3 		$612 Buy
+40
New +$631 ﹤0.01% 3066
2024
Q2 		– Sell
-67
Closed -$1.26K – 3234
2024
Q1 		$1.26K Buy
67
+25
+60% +$432 ﹤0.01% 2912
2023
Q4 		$802 Sell
42
-18
-30% -$288 ﹤0.01% 2934
2023
Q3 		$1.08K Buy
60
+30
+100% +$603 ﹤0.01% 2923
2023
Q2 		$609 Sell
30
-46
-61% -$876 ﹤0.01% 3052
2023
Q1 		$1.39K Buy
76
+64
+533% +$1.22K ﹤0.01% 2910
2022
Q4 		$248 Sell
12
-1
-8% -$28 ﹤0.01% 3177
2022
Q3 		$0 Buy
+13
New +$344 ﹤0.01% 3303
2022
Q2 		– Sell
-26
Closed -$1K – 3302
2022
Q1 		$1K Hold
26
– – ﹤0.01% 3046
2021
Q4 		$1K Buy
+26
New +$1.01K ﹤0.01% 2980
2021
Q3 		– Sell
-26
Closed -$1K – 3181
2021
Q2 		$1K Sell
26
-88
-77% -$2.51K ﹤0.01% 2805
2021
Q1 		$3K Buy
+114
New +$3.97K ﹤0.01% 2372

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

SignatureFD's RCUS Position: Q1 2025 in Review

SignatureFD sold out of Arcus Biosciences (RCUS) in Q1 2025, closing a stake of 40 shares — an estimated $596 sold.

SignatureFD first reported a position in RCUS in Q1 2021 and held it in 13 quarters. The position peaked at $3K in Q1 2021. 186 funds tracked by Wall St. Rank hold RCUS as of Q1 2025.

  • SignatureFD reported no remaining Arcus Biosciences position as of Q1 2025 after selling out during the quarter.
  • SignatureFD sold 40 Arcus Biosciences shares in Q1 2025, an estimated $596.
  • SignatureFD first reported a position in Arcus Biosciences in Q1 2021 and held it in 13 quarters.
  • SignatureFD's Arcus Biosciences position peaked at $3K in Q1 2021.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2025.

Based on SignatureFD's 13F filing for Q1 2025, filed 2 May 2025.